CONTENTS:
- "Pressed OXY M30 pills, great press, potent, fast shipping!!!": Availability of counterfeit and pharmaceutical oxycodone pills on one major cryptomarket. Lamy F.R., Daniulaityte R., Dudley S., Jr., p. 1-7.
- Kratom retail availability in Fort Worth, Texas. LoParco C.R., Yockey R.A., Sekhon V.K., Olsson S., Galindo R., Balasundaram R., et al., p. 8-13.
- Kratom: A bibliometric analysis of scientific publications. Phoong S.W., Phoong S.Y., Yeoh Y.J., p. 14-22.
- Ketamine-assisted group psychotherapy for frontline healthcare workers with COVID-19-related burnout and PTSD: A case series of effectiveness/safety for 10 participants. Robison R., Brendle M., Moore C., Cross H., Helm L., Darling S., et al., p. 23-32.
- Pronounced regional variation in esketamine and ketamine prescribing to US Medicaid patients. Aguilar A.G., Beauregard B.A., Conroy C.P., Khatiwoda Y.T., Horsford S.M.E., Nichols S.D., et al., p. 33-39.
- Epidemiology of Khat (Catha edulis) chewing in Ethiopia: A systematic review and meta-analysis. Ayano G., Ayalew M., Bedaso A., Duko B., p. 40-49.
- Menstrual changes and reversal of amenorrhea induced by classic psychedelics: A case series. Gukasyan N., Narayan S.K., p. 50-55.
- Educational materials and image induction increase treatment credibility. Low F., Earleywine M., p. 56-65.
- Screening and brief intervention for cannabis misuse in individuals on buprenorphine treatment for opioid use disorder: Double-blind randomized clinical trial. Sharma B., Ghosh A., Pillai R.R., Basu D., p. 66-75.
- Cocaine effect expectancies among patients with cocaine use disorder with and without adult attention deficit hyperactivity disorder: Are there any relevant differences? Gonzalez-Saiz F., Trujols J., Vergara-Moragues E., p. 76-87.
- Effects of positive versus negative framing on stigma toward individuals recovering from methamphetamine use disorder during randomized brief video exposure. Schutz C., Smout M.F., p. 88-96.
- Comparison of emotional processing between patients with substance use disorder and those with dual diagnosis: Relationship with severity of dependence and use during treatment. Gomez-Bujedo J., Dacosta-Sanchez D., Pérez-Moreno P.J., Garcia Garcia A., Diaz-Batanero C., Fernandez-Calderon F., et al., p. 97-108.
- Identity construction in recovery from substance use disorders. Chen G., p. 109-116.
- Prevalence and predictors of psychoactive drug use among Chinese men who have sex with men: A longitudinal and mediation study. Yang X., Mo P.K.H., Ip M.T.K., Wang Z., p. 117-126.
- "It's also pushed people to a new level of desperation:" COVID-19 impacts on experiences of persons who use illicit opioids. Sweeney K., Daniulaityte R., Mendoza N., Ki S., Doebbeling B., p. 127-134.
- O-Know Opioid Knowledge test: Development and psychometric testing in a community setting. Gregory V.L., Jr., Ofner S., Ellis R.J., p. 135-145.
- Determinants of hardcore smoking in a MULTI-ETHNIC study of cigarette smokers in Singapore. Feng Z., Tan C.S., Lee J.K., p. 146-156.